A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program

Acta Diabetologica

Volumn 52, Issue 3, 2015, Pages 625-628

  Zhang, Chao ^a,b   Luo, Hao ^c   Gao, Feng ^c   Zhang, Chun Ting ^c   Zhang, Ren ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c TIANJIN UNIVERSITY   (China)

Author keywords

Adiponectin; Subcutaneous adipose tissue; Visceral adipose tissue

Indexed keywords

ADIPONECTIN; METFORMIN; PLACEBO;

AGE DISTRIBUTION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES CONTROL; DIABETES PREVENTION PROGRAM; EXERCISE; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; INTRAABDOMINAL FAT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; SEX DIFFERENCE; SUBCUTANEOUS FAT; WEIGHT REDUCTION; ADULT; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; LIFESTYLE; METABOLISM; MIDDLE AGED; PSYCHOLOGY;

ADIPONECTIN; ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LIFE STYLE; MALE; MIDDLE AGED; SUBCUTANEOUS FAT;

EID: 84930087193     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0655-2     Document Type: Article

References (5)

1. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116(7):1784–1792
2. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, Pfeiffer AF (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361(9353):226–228
3. Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R (2008) Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 57(4):980–986
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403
5. Fujimoto WY, Jablonski KA, Bray GA, Kriska A, Barrett-Connor E, Haffner S, Hanson R, Hill JO, Hubbard V, Stamm E, Pi-Sunyer FX (2007) Body size and shape changes and the risk of diabetes in the Diabetes Prevention Program. Diabetes 56(6):1680–1685